Company news

Ligand Pharmaceuticals Incorporated news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Ligand Pharmaceuticals Management to Present at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference

August 31, 2020

Ligand Commences Previously Announced Cash Tender Offer to Acquire Pfenex Inc.

August 30, 2020

Ligand OmniAb® Partner Immunovant Announced Positive Topline Results from Multicenter, Placebo-Controlled Phase 2a Trial of IMVT-1401 in Myasthenia Gravis

August 24, 2020

Ligand Announces Amgen’s KYPROLIS® Approved by FDA as Combination Regimen with DARZALEX® and Dexamethasone in Once- and Twice-Weekly Dosing Regimens for Patients with Relapsed/Refractory Multiple Myeloma

August 23, 2020

Ligand to Acquire Pfenex Inc.

August 9, 2020

Ligand Reports Second Quarter 2020 Financial Results

August 2, 2020

Ligand’s Second Quarter Financial Results to be Reported August 3rd

July 15, 2020

Functional, Human Antibodies Targeting SARS-CoV-2 Discovered Using IPA's Proprietary B cell Select™ and Single Step Cloning Hybridoma Technologies

July 12, 2020

Ligand Announces an Expansion of Vernalis Collaboration with Servier for Research on Novel Oncology Targets

June 14, 2020

Ligand CEO Issues Letter to Captisol Customers

May 31, 2020

Ligand Announces Icagen’s Expansion of Collaboration with Roche to Develop and Commercialize Therapies for Neurological Diseases

May 28, 2020

Ligand Earns $3 Million Milestone Payment from Palvella Therapeutics

May 27, 2020

Ligand Reports First Quarter 2020 Financial Results

May 5, 2020

Ligand’s First Quarter Financial Results to be Reported May 6th

April 21, 2020

Ligand Provides a Corporate Update and Announces May 6th as the Date for First Quarter Earnings Call

April 5, 2020

Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs and Ion Channel Technologies

April 1, 2020

Ligand’s Presentation at the Barclays Global Healthcare Conference Now a Webcast Only, New Slides Available on Ligand.com

March 9, 2020

Ligand Pharmaceuticals Management to Present at Two Investor Conferences in March

March 1, 2020

Ligand Raises 2020 Financial Guidance Due to Higher Captisol Material Sales

February 26, 2020

Ligand Agrees to Acquire Core Assets, Partnered Programs and Ion Channel Technologies from Icagen

February 10, 2020

Ligand Reports Fourth Quarter and Full Year 2019 Financial Results

February 5, 2020

Ligand's Technologies Support and Enable Potential Coronavirus Treatments

February 2, 2020

Ligand Enters into OmniAb® Platform License Agreement with Pandion Therapeutics

January 12, 2020

Ligand to Report 2019 Fourth Quarter and Full Year Financial Results on February 6th

January 8, 2020

Two Ligand Pharmaceuticals Board Members Recognized as 2019 Most Influential Corporate Directors by WomenInc. Magazine

December 22, 2019

Ligand Enters into Worldwide OmniAb® Platform License Agreement with Sanofi

December 1, 2019

Ligand Pharmaceuticals Ranked in Deloitte’s 2019 Technology Fast 500™

November 11, 2019

Ligand Presents Positive Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol

November 7, 2019

Ligand to Participate in the Stephens 2019 Nashville Investment Conference

November 6, 2019

Ligand Reports Third Quarter 2019 Financial Results

November 4, 2019

Ligand to Report Third Quarter 2019 Results on November 5th

October 21, 2019

Ligand Appoints Pharmaceutical Executive Sarah Boyce to its Board of Directors

October 14, 2019

Ligand and SQ Innovation Enter into Exclusive Worldwide Captisol® License and Supply Agreements for High-Concentration Furosemide Formulation

July 7, 2019

← Newer news releases

Calls

The 5 newest of 24 calls. Every call is listed under its year.

Decks

The 5 newest of 45 decks. Every deck is listed under its year.